多发性硬化症的干细胞移植:公布研究的2023年审查
Ali Msheik1, Farah Assi2, Faten Hamed3
1Neurological Surgery, Faculty of Medicine Lebanese University, Hadath, LBN.
Cureus
|November 30, 2023
概括
干细胞移植 (SCT) 通过减少疾病活动和进展,对多发性硬化症 (MS) 有望. 造血干细胞移植 (HSCT) 可能比疾病修饰疗法 (DMT) 提供更好的结果,但治疗应该是个性化的.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统的一种慢性脱髓化疾病.
- 目前的疾病修饰疗法 (DMT) 旨在治疗多发性硬化症,但在阻止疾病进展方面可能存在局限性.
- 干细胞移植 (SCT) 正成为MS的潜在治疗策略.
研究的目的:
- 综合审查有关MSST对MS的有效性,安全性和可行性的文献.
- 综合各种研究设计的证据,包括RCT,观察性,回顾性和比较性研究.
- 评估SCT对MS疾病活动,进展和患者结局的影响.
主要方法:
- 系统的文献审查遵循PRISMA指南.
- 包括随机对照试验 (RCT),观察性,回顾性和比较性研究.
- 对疾病活动,病变负担,复发率,残疾分数 (EDSS) 和没有疾病活动证据 (NEDA) 的数据的分析.
主要成果:
- 有机试验 (ASTIMS,MIST) 表明,SCT可以减少复发性复发性多发性硬化 (RRMS) 的新病变和炎症活性.
- 观察性和回顾性研究支持SCT的潜力,显示复发率下降和EDSS得分改善.
- 与DMT相比,接受血造干细胞移植 (HSCT) 的患者表现出较低的进展/复发率和减少的T2病变.
结论:
- 干细胞移植 (SCT) 是治疗多发性硬化症 (MS) 的一个有前途的治疗方案.
- 与传统的DMT相比,HSCT在疾病控制和病变减少方面可能提供更好的结果.
- 个性化患者评估,疾病阶段和治疗反应对于在MS中最佳的SCT部署至关重要.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.


